Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sutherland

Showing results (861-870 of 999) with videos related to

Pageof 100
Sort By:
Nature Communications|December 31, 2024
Genome sequencing of Plasmodium malariae identifies continental segregation and mutations associated with reduced pyrimethamine susceptibilityAmy Ibrahim, Franziska Mohring, Emilia Manko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Allografting for indolent lymphoid neoplasmsC L Toze, J D Shepherd, J M Connors, et al.
Scientific Reports|October 20, 2018
Global genetic diversity of var2csa in Plasmodium falciparum with implications for malaria in pregnancy and vaccine developmentErnest Diez Benavente, Damilola R Oresegun, Paola Florez de Sessions, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantationDonna L Forrest, Donna E Hogge, Thomas J Nevill, et al.
Plos One|January 24, 2013
The 50 most important questions relating to the maintenance and restoration of an ecological continuum in the European AlpsChris Walzer, Christine Kowalczyk, Jake M Alexander, et al.
Mbio|February 25, 2026
Novel <i>Pfk13</i> and <i>Pfubp1</i> genotypes in African <i>Plasmodium falciparum</i> isolates exhibiting reduced susceptibility to the antimalarials artemisinin and lumefantrineSade Pratt, Donelly A van Schalkwyk, Lindsay Stewart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2009
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantationMatthew P Wright, John D Shepherd, Michael J Barnett, et al.
Cancer Genetics and Cytogenetics|September 13, 2006
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factorsYulia Lin, Hélène Bruyère, Douglas E Horsman, et al.
JCI Insight|May 4, 2018
Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairmentGraciela Andonegui, Erin L Zelinski, Courtney L Schubert, et al.
Leukemia & Lymphoma|July 16, 2005
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remissionKevin W Song, Peter N Mollee, Donna E Hogge, et al.
Pageof 100

Showing results (861-870 of 999) with videos related to

Sort By:
Pageof 100
Nature Communications|December 31, 2024
Genome sequencing of Plasmodium malariae identifies continental segregation and mutations associated with reduced pyrimethamine susceptibilityAmy Ibrahim, Franziska Mohring, Emilia Manko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Allografting for indolent lymphoid neoplasmsC L Toze, J D Shepherd, J M Connors, et al.
Scientific Reports|October 20, 2018
Global genetic diversity of var2csa in Plasmodium falciparum with implications for malaria in pregnancy and vaccine developmentErnest Diez Benavente, Damilola R Oresegun, Paola Florez de Sessions, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantationDonna L Forrest, Donna E Hogge, Thomas J Nevill, et al.
Plos One|January 24, 2013
The 50 most important questions relating to the maintenance and restoration of an ecological continuum in the European AlpsChris Walzer, Christine Kowalczyk, Jake M Alexander, et al.
Mbio|February 25, 2026
Novel <i>Pfk13</i> and <i>Pfubp1</i> genotypes in African <i>Plasmodium falciparum</i> isolates exhibiting reduced susceptibility to the antimalarials artemisinin and lumefantrineSade Pratt, Donelly A van Schalkwyk, Lindsay Stewart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2009
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantationMatthew P Wright, John D Shepherd, Michael J Barnett, et al.
Cancer Genetics and Cytogenetics|September 13, 2006
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factorsYulia Lin, Hélène Bruyère, Douglas E Horsman, et al.
JCI Insight|May 4, 2018
Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairmentGraciela Andonegui, Erin L Zelinski, Courtney L Schubert, et al.
Leukemia & Lymphoma|July 16, 2005
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remissionKevin W Song, Peter N Mollee, Donna E Hogge, et al.
Pageof 100